AngioDynamics Inc. (ANGO)
NASDAQ: ANGO
· Real-Time Price · USD
9.38
-0.19 (-1.99%)
At close: May 22, 2025, 3:59 PM
9.41
0.32%
After-hours: May 22, 2025, 04:04 PM EDT
AngioDynamics Revenue Breakdown
| Period Ending | May 31, 2024 | May 31, 2022 |
|---|---|---|
| Med Device Revenue | 197.51M | 237.5M |
| Med Device Revenue Growth | -16.84% | n/a |
| Med Tech Revenue | 106.4M | 78.72M |
| Med Tech Revenue Growth | +35.17% | n/a |
Operating Expense Breakdown
| Period Ending | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 35.99M | 35.98M | 36.58M | 35.02M | 35.98M | 34.75M | 38.22M | 36.52M | 34.24M | 36.84M | 36.64M | 37.94M | 29.14M | 33.28M | 33.39M | 32.95M | 28.62M | 29.39M | 26.26M | 26.43M | 31.14M | 31.11M | 27.83M | 30.4M | 28.19M | 29.61M | 27.93M | 28.84M | 25.73M | 26.51M | 27.46M | 28.79M | 26.47M | 27.31M | 27.66M | 28.1M | 27.09M | 28.66M | 27.99M | 27.88M | 26.27M |
| Selling, General, and Administrative Revenue Growth | +0.04% | -1.64% | +4.45% | -2.67% | +3.54% | -9.08% | +4.66% | +6.65% | -7.05% | +0.54% | -3.41% | +30.17% | -12.44% | -0.31% | +1.33% | +15.14% | -2.64% | +11.92% | -0.63% | -15.12% | +0.10% | +11.76% | -8.46% | +7.84% | -4.77% | +6.00% | -3.17% | +12.09% | -2.92% | -3.46% | -4.63% | +8.78% | -3.07% | -1.26% | -1.57% | +3.74% | -5.49% | +2.40% | +0.39% | +6.11% | n/a |
| Research and Development Revenue | 6.91M | 6.43M | 6.29M | 6.72M | 8.19M | 8.66M | 7.94M | 7.86M | 6.85M | 6.84M | 8.33M | 7.87M | 7.28M | 8.2M | 7.39M | 9.1M | 8.56M | 9.71M | 9.01M | 7.23M | 8.39M | 7.76M | 6.29M | 7.2M | 7.21M | 7.36M | 7.66M | 6.45M | 6.46M | 6.11M | 6.44M | 6.7M | 5.95M | 5.91M | 6.71M | 6.94M | 5.81M | 6.18M | 6.2M | 7.29M | 6.86M |
| Research and Development Revenue Growth | +7.44% | +2.37% | -6.53% | -17.89% | -5.42% | +9.03% | +1.03% | +14.71% | +0.20% | -17.94% | +5.94% | +8.05% | -11.21% | +10.89% | -18.78% | +6.29% | -11.81% | +7.80% | +24.57% | -13.85% | +8.13% | +23.39% | -12.61% | -0.14% | -2.08% | -3.90% | +18.72% | -0.05% | +5.73% | -5.19% | -3.81% | +12.52% | +0.64% | -11.86% | -3.29% | +19.44% | -6.00% | -0.37% | -14.91% | +6.33% | n/a |
| Sales and Marketing Revenue | 25.5M | 25.59M | 25.61M | 24.58M | 25.41M | 25.46M | 27.37M | 26.29M | 25.41M | 26.01M | 26.54M | 26.83M | 20.42M | 23.61M | 24.45M | 23.82M | 19.61M | 20.17M | 17.7M | 18.21M | 20.93M | 20.11M | 19.38M | 21.84M | 19.41M | 20.27M | 19.43M | 20.9M | 18.01M | 18.97M | 19.4M | 20.48M | 19.47M | 19.52M | 19.49M | 21.19M | 20.3M | 20.57M | 20.56M | 20.22M | 19.36M |
| Sales and Marketing Revenue Growth | -0.33% | -0.06% | +4.17% | -3.24% | -0.23% | -6.96% | +4.09% | +3.49% | -2.31% | -2.02% | -1.08% | +31.43% | -13.51% | -3.44% | +2.63% | +21.49% | -2.81% | +13.95% | -2.76% | -13.03% | +4.08% | +3.78% | -11.28% | +12.52% | -4.22% | +4.30% | -7.01% | +16.04% | -5.05% | -2.24% | -5.25% | +5.17% | -0.28% | +0.18% | -8.04% | +4.38% | -1.30% | +0.05% | +1.69% | +4.46% | n/a |